nok 57,60 <%= Resources.Global.txtUp %>
Opdateret 21-09-2018
Ændring % 4,35% Stigning i aktiekurs
Ændring 2,40 Stigning i aktiekurs
Volume 227.730
Høj NOK 59,00
Lav NOK 55,00
Åben NOK 56,10
ISIN NO0010000045
Seneste luk NOK 55,20
# af aktier 21,59M
Markedsværdi 1.243,79M NOK
I dag

Market closed
Photocure ASA NOK0.5
Markedet er lukket, åbner klokken 09:00
 
Kursudvikling Seneste 1 uge 1 måned 3 mdr 6 mdr 1 år
 
  57,60 4,7% Stigning i aktiekurs 25,4% Stigning i aktiekurs 86,7% Stigning i aktiekurs 106,5% Stigning i aktiekurs 140,0% Stigning i aktiekurs
Powered by TradingView

Nyheder om Photocure ASA NOK0.5

  • Dansk
  • Engelsk
  • Fondsbørsmeddelelser

Firmaprofil

PhotoCure ASA is a Norway based specialty pharmaceutical company. Its technology platform is focused on the field of photodynamic diagnosis and treatment in the areas of dermatology and cancer. The group has operations in Norway, Sweden, Denmark, Finland and the United States. The operating segments of the group are Commercial franchise and Development portfolio. The company markets product through its commercial operation in the Nordic region under the brand name Hexvix and in the US under the brand name Cysview. It generates prime revenue from the Commercial franchise segment which includes the Hexvix and Cysview products. In addition, the firm also has two device products, Cevira and Visonac, both targeted at indications with medical need and market potential.

Copyright Berlingske Media 2018  Handelsbetingelser  |  Cookiedeklaration  |  Cookie- og Privatlivspolitik  |  Ophavsret og vilkår
Aktieinformation leveres af Morningstar.
Data er forsinket 15-20 minutter iht. de enkelte børsers regler om videredistribution.
 
24. september 2018 01:48:21
(UTC+01:00) Brussels, Copenhagen, Madrid, Paris
Version: LiveBranchBuild_20180919.1 - EUROWEB3 - 2018-09-24 01:48:21 - 2018-09-24 01:48:21 - 1 - Website: OKAY